Genome-wide mutation profiles from cell-free DNA for early cancer detection

No authors listed

Comment

No authors listed. Nat Genet. 2023 Aug.

. 2023 Aug;55(8):1261-1262.

doi: 10.1038/s41588-023-01448-1.

No abstract available

Comment on

Single-molecule genome-wide mutation profiles of cell-free DNA for non-invasive detection of cancer.
Bruhm DC, Mathios D, Foda ZH, Annapragada AV, Medina JE, Adleff V, Chiao EJ, Ferreira L, Cristiano S, White JR, Mazzilli SA, Billatos E, Spira A, Zaidi AH, Mueller J, Kim AK, Anagnostou V, Phallen J, Scharpf RB, Velculescu VE. Bruhm DC, et al. Nat Genet. 2023 Aug;55(8):1301-1310. doi: 10.1038/s41588-023-01446-3. Epub 2023 Jul 27. Nat Genet. 2023. PMID: 37500728 Free PMC article.

1. Sung, H. et al. Global Cancer Statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. Ca Cancer J. Clin. 71, 209–249 (2021). This study reports global estimates of cancer incidence and mortality. - DOI - PubMed
1. American Cancer Society. American Cancer Society Guidelines for the Early Detection of Cancer. https://www.cancer.org/content/dam/CRC/PDF/Public/912.00.pdf (2023). This presents the American Cancer Society guidelines for cancer screening.
1. Centers for Disease Control and Prevention, National Center for Health Statistics. Lung Cancer National Health Interview Survey. https://progressreport.cancer.gov/detection/lung_cancer (2021). This is an online summary of trends in cancer control measures in the USA.
1. National Lung Screening Trial Research Team. Reduced lung-cancer mortality with low-dose computed tomographic screening. N. Engl. J. Med. 365, 395–409 (2011). This study reports the results of a large national lung-cancer-screening trial. - DOI
1. Cristiano, S. et al. Genome-wide cell-free DNA fragmentation in patients with cancer. Nature 570, 385–389 (2019). This paper describes the DELFI approach for non-invasive detection of cancer. - DOI - PubMed